Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Chemistry Officer
-
Issuer Symbol
-
PRLD on Nasdaq
Andrew Combs - trading volume in the past year for Prelude Therapeutics Inc
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
480,123 |
$332,485 |
$0.6925 |
25 Mar 2025 |
Direct |
|
|
| Employee Stock Option (right to buy) |
230,000 |
|
|
04 Feb 2026 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.